Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Orthopaedics
Published in: International Orthopaedics 8/2014

01-08-2014 | Original Paper

Targeted pre-operative autologous blood donation: a prospective study of two thousand and three hundred and fifty total hip arthroplasties

Authors: Jad Bou Monsef, Mark P. Figgie, David Mayman, Friedrich Boettner

Published in: International Orthopaedics | Issue 8/2014

Login to get access

Abstract

Purpose

Pre-operative donation of autologous blood has been widely used in elective joint replacement procedures to avoid the risks of allogeneic blood transfusions. However, the high percentage of wasted autologous blood questions the general efficacy of pre-operative autologous blood donation (PABD) for all patients undergoing hip replacement. This study prospectively investigates the impact of a targeted pre-operative autologous blood donation protocol for anaemic patients on allogeneic and overall transfusion rates in 2,350 unilateral primary total hip arthroplasty procedures.

Methods

Patients with pre-operative haemoglobin less than 12.5 g/dL were advised to donate one unit of autologous blood seven to 15 days prior to the date of surgery. The targeted protocol was followed by 2,251 patients: 280 out of 367 anaemic patients donated while 1,971 out of 1,983 non-anaemic patients did not donate.

Results

Results showed a significantly lower rate of allogeneic transfusion for anaemic patients who predonated than anaemic patients who did not (13 % vs. 37 % respectively, p < 0.001). Overall transfusion rates for patients who followed the protocol (n = 2,251) were found to be 0.17 units/patient compared to previously reported numbers of 0.75 units/patient when routine donation was used. Among the 2,251 patients who followed the protocol, only 140 patients (6 %) had their autologous blood wasted, in contrast to values reported in the literature ranging from 14 % up to 50 %.

Conclusions

Targeted PABD reduces the need for allogeneic blood transfusion in anaemic patients and significantly reduces the overall number of transfusions compared to routine pre-operative autologous donation.
Literature
1.
2.
Newman ET, Watters TS, Lewis JS, Jennings JM, Wellman SS, Attarian DE, Grant SA, Green CL, Vail TP, Bolognesi MP (2014) Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Joint Surg Am 96(4):279–284. doi:10.​2106/​JBJS.​L.​01041 PubMedCrossRef
3.
Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL (2000) Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am 82(1):89–100PubMed
4.
Parvizi J, Chaudhry S, Rasouli MR, Pulido L, Joshi A, Herman JH, Rothman RH (2011) Who needs autologous blood donation in joint replacement? J Knee Surg 24(1):25–31PubMedCrossRef
5.
Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB (1999) An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 81(1):2–10PubMed
6.
Salido JA, Marin LA, Gomez LA, Zorrilla P, Martinez C (2002) Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 84-A(2):216–220PubMed
7.
de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC (1996) Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop (Belle Mead NJ) 25(8):533–542
8.
Keating EM, Meding JB, Faris PM, Ritter MA (1998) Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res 357:50–59PubMedCrossRef
9.
Aggarwal AK, Shashikanth VS, Marwaha N (2014) Platelet-rich plasma prevents blood loss and pain and enhances early functional outcome after total knee arthroplasty: a prospective randomised controlled study. Int Orthop 38(2):387–395. doi:10.​1007/​s00264-013-2136-6 PubMedCrossRef
10.
Buljan M, Nemet D, Golubic-Cepulic B, Bicanic G, Tripkovic B, Delimar D (2012) Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty. Int Orthop 36(4):703–709. doi:10.​1007/​s00264-011-1367-7 PubMedCentralPubMedCrossRef
11.
12.
Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL (2003) Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 43(4):459–469PubMedCrossRef
13.
Sharrock NE, Salvati EA (1996) Hypotensive epidural anesthesia for total hip arthroplasty: a review. Acta Orthop Scand 67(1):91–107PubMedCrossRef
14.
15.
16.
Boettner F, Altneu EI, Williams BA, Hepinstall M, Sculco TP (2009) Nonanemic patients do not benefit from autologous blood donation before total hip replacement. HSS J 6(1):66–70. doi:10.​1007/​s11420-009-9145-4
17.
18.
Henry DA, Carless PA, Moxey AJ, O’Connell D, Forgie MA, Wells PS, Fergusson D (2002) Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2):CD003602. doi:10.​1002/​14651858.​CD003602
19.
Callaghan JJ, Spitzer AI (2000) Blood management and patient specific transfusion options in total joint replacement surgery. Iowa Orthop J 20:36–45PubMedCentralPubMed
20.
Billote DB, Glisson SN, Green D, Wixson RL (2002) A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am 84-A(8):1299–1304PubMed
21.
Jakovina Blazekovic S, Bicanic G, Hrabac P, Tripkovic B, Delimar D (2014) Pre-operative autologous blood donation versus no blood donation in total knee arthroplasty: a prospective randomised trial. Int Orthop 38(2):341–346. doi:10.​1007/​s00264-013-2185-x PubMedCrossRef
22.
Metadata
Title
Targeted pre-operative autologous blood donation: a prospective study of two thousand and three hundred and fifty total hip arthroplasties
Authors
Jad Bou Monsef
Mark P. Figgie
David Mayman
Friedrich Boettner
Publication date
01-08-2014
Publisher
Springer Berlin Heidelberg
Published in
International Orthopaedics / Issue 8/2014
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-014-2339-5

Other articles of this Issue 8/2014

International Orthopaedics 8/2014 Go to the issue

Original Paper

Olecranon fractures: factors influencing re-operation

Original Paper

Excessive polyethylene wear and acetabular bone defects from standard use of a hooded acetabular insert in total hip arthroplasty

Review Article

Osteoporosis and the orthopaedic surgeon: basic concepts for successful co-management of patients’ bone health

Original Paper

Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplasty

Original Paper

Better results with patelloplasty compared to traditional total knee arthroplasty

Letter to the Editor

Iliac crest bone grafting: raising awareness of a common pitfall